16. Tumor Hypoxia
Breast Cancer 2026 investigates tumor hypoxia, a condition characterized by reduced oxygen availability within tumor tissues that influences cancer progression and therapeutic resistance. It remains a major factor affecting treatment effectiveness.
Improves understanding of aggressive disease behaviour and opportunities for targeted therapies.
Key Highlights:
16.1 Hypoxic Signalling Pathways
16.2 Treatment Resistance
16.3 Tumor Adaptation Mechanisms
16.4 Hypoxia Biomarkers
16.5 Therapeutic Targeting Strategies